Technomark Medical Ventures
2
18M
1
1
0.50
1
- Areas of investment
Summary
The main department of described VC is located in the London. The fund was located in Europe if to be more exact in United Kingdom.
The important activity for fund was in 2001. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2011. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The standard case for the fund is to invest in rounds with 6 partakers. Despite the Technomark Medical Ventures, startups are often financed by West Deutsche Landesbank Girozentrale, Excalibur Fund Managers. The meaningful sponsors for the fund in investment in the same round are West Deutsche Landesbank Girozentrale, Temasek Holdings, Scottish Equity Partners. In the next rounds fund is usually obtained by Scottish Equity Partners, Triathlon Medical Venture Partners, New Science Ventures.
For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline BioVex Among the most popular fund investment industries, there are Medical, Biotechnology.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Exits
- 1
- Follow on index
- 0.50
- Investments by industry
- Health Care (2)
- Biotechnology (2)
- Medical (2)
- Investments by region
-
- United Kingdom (2)
- Peak activity year
- 2003
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Avg. valuation at time of investment
- 1B
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
- Avg. multiplicator
- 8.61
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| BioVex | 30 Jul 2001 | Biotechnology, Health Care, Medical | Early Stage Venture | 13M | United Kingdom, England |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.